A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes
Genomic Profiling and Matched Therapy for Recurrent or Metastatic Salivary Gland Neoplasms
Sponsor: University Health Network, Toronto
This NA trial investigates Advanced and Metastatic and is currently completed. University Health Network, Toronto leads this study, which shows 13 recorded versions since 2014 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
13 versions recorded-
Feb 2026 — Present [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2024 — Feb 2026 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Feb 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2022 — Feb 2024 [monthly]
Recruiting NA
▶ Show 8 earlier versions
-
Mar 2022 — Sep 2022 [monthly]
Recruiting NA
-
Dec 2021 — Mar 2022 [monthly]
Recruiting NA
-
Jan 2021 — Dec 2021 [monthly]
Recruiting NA
-
Oct 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Jan 2020 — Oct 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Mar 2019 — Jan 2020 [monthly]
Recruiting NA
-
Jun 2018 — Mar 2019 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jun 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Health Network, Toronto
For direct contact, visit the study record on ClinicalTrials.gov .